Monoclonal Antibody Treatment for COVID-19

Treatment is here

Throughout this pandemic, scientists and researchers collectively came together to discover unique ways to treat patients with COVID-19. At Virtua, we're beyond delighted to share this groundbreaking therapy with our community. With early studies suggesting that monoclonal antibodies reduce COVID-19 symptoms more quickly - we genuinely believe it's going to make a significant impact for our patients.

How does monoclonal antibody treatment work?
When you get sick, your immune system powers up and creates antibodies. Those antibodies stick to a specific target, like a virus, to render them harmless. Monoclonal antibodies are engineered proteins that act like human antibodies in your immune system. We’ve been authorized by the FDA to offer monoclonal antibody therapy for individuals who meet set criteria.

Am I eligible for monoclonal antibody treatment?
It depends. As part of the emergency use authorization, treatment is reserved for high-risk, non-hospitalized COVID-19 patients experiencing mild to moderate symptoms. Such risk factors include a BMI (body mass index) of 25 or higher, chronic kidney disease, diabetes, immunosuppressive disease or receiving immunosuppressive treatment, age 65 or older, or age 55 or older with certain chronic conditions. If you have any questions, give us a call at 888-847-8823.

How is monoclonal antibody treatment administered?
Regeneron, a monoclonal antibody, is administered through an IV for approximately 30 minutes. After the procedure, we'll monitor you to ensure you're not experiencing any dramatic side effects, likely for one hour. 

When should I receive monoclonal antibody treatment?
Timing is everything. In clinical trials, people who received treatment within ten days of experiencing symptoms were less likely to go to the hospital, and, in general, had more favorable outcomes. The trials also found that the treatment may limit the duration of the virus in the body. 

Is monoclonal antibody treatment safe?
With all IV-based infusions, you can expect some sore muscles or bruising. However, in some cases, rare allergic reactions have occurred during or after the infusion. So please tell us if you're experiencing fever, chills, shortness of breath, or other unusual symptoms. 

Please see the media coverage section on our COVID-19 news and media page for selected news articles on monoclonal antibody treatment.